Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of NUTRAPLUS PR. For more details, see the NUTRAPLUS PR quarterly results and NUTRAPLUS PR share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 34.09 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 7.3/1.8 |
No. of Mths Year Ending |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
5-Yr Chart Click to enlarge
|
---|
NUTRAPLUS PR EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 494 | 212 | 51 | 35 | 22 | |
Low | Rs | 114 | 20 | 21 | 13 | 5 | |
Sales per share (Unadj.) | Rs | 54.4 | 23.6 | 31.5 | 33.6 | 25.6 | |
Earnings per share (Unadj.) | Rs | 6.3 | -2.1 | 0 | 0.6 | -14.0 | |
Diluted earnings per share | Rs | 2.3 | -2.1 | 0.0 | 0.6 | -14.0 | |
Cash flow per share (Unadj.) | Rs | 7.6 | -1.4 | 1.2 | 1.8 | -12.7 | |
Dividends per share (Unadj.) | Rs | 0.25 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.1 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 45.9 | 19.7 | 19.7 | 20.4 | 6.3 | |
Adj. book value per share | Rs | 17.1 | 19.7 | 19.7 | 20.4 | 6.3 | |
Shares outstanding (eoy) | m | 12.67 | 34.09 | 34.09 | 34.09 | 34.09 | |
Price / Sales ratio | x | 5.6 | 4.9 | 1.1 | 0.7 | 0.5 | |
Avg P/E ratio | x | 48.6 | -55.3 | 882.0 | 37.4 | -1.0 | |
P/CF ratio (eoy) | x | 39.9 | -80.1 | 30.6 | 13.2 | -1.1 | |
Price / Book Value ratio | x | 6.6 | 5.9 | 1.8 | 1.2 | 2.1 | |
Dividend payout | % | 4.0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 3,854 | 3,944 | 1,228 | 818 | 464 | |
Total wages/salary | Rs m | 29 | 35 | 37 | 41 | 73 |
NUTRAPLUS PR INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 690 | 804 | 1,073 | 1,145 | 873 | |
Other income | Rs m | 3 | 3 | 2 | 39 | 1 | |
Total revenues | Rs m | 693 | 807 | 1,075 | 1,184 | 875 | |
Gross profit | Rs m | 133 | -19 | 92 | 104 | -358 | |
Depreciation | Rs m | 17 | 22 | 39 | 40 | 47 | |
Interest | Rs m | 49 | 50 | 47 | 69 | 74 | |
Profit before tax | Rs m | 70 | -88 | 9 | 34 | -478 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -9 | -17 | 7 | 12 | 0 | |
Profit after tax | Rs m | 79 | -71 | 1 | 22 | -478 | |
Gross profit margin | % | 19.3 | -2.3 | 8.6 | 9.1 | -41.0 | |
Effective tax rate | % | -12.6 | 19.3 | 84.2 | 34.9 | 0 | |
Net profit margin | % | 11.5 | -8.9 | 0.1 | 1.9 | -54.8 |
NUTRAPLUS PR BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 950 | 823 | 776 | 700 | 178 | |
Current liabilities | Rs m | 631 | 710 | 629 | 631 | 890 | |
Net working cap to sales | % | 46.3 | 14.1 | 13.7 | 6.0 | -81.5 | |
Current ratio | x | 1.5 | 1.2 | 1.2 | 1.1 | 0.2 | |
Inventory Days | Days | 22 | 19 | 14 | 13 | 1 | |
Debtors Days | Days | 134,647,095 | 118,713,854 | 85,135,243 | 52,360,723 | 11,562,625 | |
Net fixed assets | Rs m | 705 | 869 | 939 | 997 | 939 | |
Share capital | Rs m | 127 | 170 | 170 | 170 | 170 | |
"Free" reserves | Rs m | 455 | 502 | 502 | 524 | 46 | |
Net worth | Rs m | 582 | 672 | 672 | 694 | 216 | |
Long term debt | Rs m | 389 | 321 | 417 | 363 | 2 | |
Total assets | Rs m | 1,656 | 1,692 | 1,715 | 1,697 | 1,117 | |
Interest coverage | x | 2.5 | -0.8 | 1.2 | 1.5 | -5.4 | |
Debt to equity ratio | x | 0.7 | 0.5 | 0.6 | 0.5 | 0 | |
Sales to assets ratio | x | 0.4 | 0.5 | 0.6 | 0.7 | 0.8 | |
Return on assets | % | 7.7 | -1.3 | 2.8 | 5.3 | -36.2 | |
Return on equity | % | 13.6 | -10.6 | 0.2 | 3.2 | -221.3 | |
Return on capital | % | 12.2 | -3.9 | 5.1 | 9.7 | -185.1 | |
Exports to sales | % | 0 | 0 | 0.4 | 0.7 | 1.3 | |
Imports to sales | % | 21.3 | 10.3 | 6.5 | 7.6 | 0.7 | |
Exports (fob) | Rs m | 0 | 0 | 4 | 8 | 11 | |
Imports (cif) | Rs m | 147 | 83 | 70 | 87 | 6 | |
Fx inflow | Rs m | 0 | 0 | 4 | 8 | 11 | |
Fx outflow | Rs m | 149 | 83 | 70 | 87 | 6 | |
Net fx | Rs m | -149 | -83 | -65 | -79 | 5 |
NUTRAPLUS PR CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -96 | 197 | 67 | 124 | 91 | |
From Investments | Rs m | -344 | -186 | -107 | -97 | -27 | |
From Financial Activity | Rs m | 355 | -19 | 40 | -27 | -76 | |
Net Cashflow | Rs m | -85 | -8 | -0 | -0 | -12 |
Share Holding
Shareholding as on Jun 2020
|
Company Information
|
CHM: Mukesh D Naik | YEAR OF INC: 1990 | BSE CODE: 524764 | FV (Rs): 5 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare NUTRAPLUS PR With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.